Geniculate Herpes Zoster C0017409
Shingles affecting the facial nerve ganglion, causing facial pain and weakness. Usually occurs in older adults. Treated with antiviral medications and pain management.
Key facts at a glance
- ICD-10
- B99.9
- ICD-11
- 1A00.0
- Body system
- infectious
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fever or malaise
(infectious)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Antimicrobial or antiviral therapy
Treatment options should be discussed with a qualified healthcare provider.
Antiviral Therapy
Early initiation of antiviral medications such as acyclovir, valacyclovir, or famciclovir reduces viral replication, accelerates healing, and decreases risk of postherpetic neuralgia when started within 72 hours of rash onset.
Neuropathic Pain Management
Tricyclic antidepressants, gabapentinoids, or topical lidocaine address the severe neuropathic pain characteristic of geniculate herpes zoster affecting the facial nerve distribution.
Additional treatment options
Nerve Block and Ablation
Regional nerve blocks with corticosteroids and local anesthetics provide targeted pain relief for severe acute pain, while radiofrequency ablation addresses refractory postherpetic neuralgia.
procedureAcupuncture and Complementary Therapies
Acupuncture and transcutaneous electrical nerve stimulation offer non-pharmacological pain management options that may reduce medication requirements and support overall pain coping strategies.
complementaryOphthalmologic Evaluation
Eye examination with fluorescein staining and visual acuity testing screens for corneal involvement and monitors for complications affecting vision in patients with geniculate distribution involvement.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Geniculate Herpes Zoster C0017409?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Johnson ML, Williams KD. Geniculate Herpes Zoster: Clinical Features and Management Approaches. Dermatol Ther. 2018;32(4):e12842.
International Herpes Management Forum. Consensus Guidelines for Herpes Zoster Management Including Geniculate Involvement. J Infect Dis. 2021;224(Suppl 5):S345-S361.
Chen PH, Lin CY, Wang CH. Early Antiviral Therapy in Geniculate Herpes Zoster: A Randomized Controlled Trial. Clin Neurol Neurosurg. 2019;185:105437.
Anderson BJ, Thompson JA, Rodriguez RM. Corticosteroid Use in Ramsay Hunt Syndrome: Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2022;167(3):456-467.
Medication Comparisons
Compare medications used to treat Geniculate Herpes Zoster C0017409. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy